Surface Solutions Business of Merck KGaA, Darmstadt, Germany, Announces Price Adjustment
Darmstadt, Germany, December 21, 2018 – Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that its Surface Solutions business unit will raise the prices for its portfolio of effect pigments, cosmetic active ingredients and other functional materials worldwide. The price will increase by 5-15% depending on the specific product. Details will be communicated directly to the customers.
According to Merck KGaA, Darmstadt, Germany, the price adjustment became necessary due to a significant increase in costs for raw materials as well as for labor, energy and logistics. In addition, increased regulatory requirements further contributed to higher production costs.
The Surface Solutions business unit is part of Performance Materials at Merck KGaA, Darmstadt, Germany. This business sector comprises the specialty chemicals business of Merck KGaA, Darmstadt, Germany and supplies solutions for displays, computer chips and surfaces of every kind.
All Merck KGaA, Darmstadt, Germany, press releases are distributed by e-mail at the same time they become available on the EMD Group Website. In case you are a resident of the USA or Canada please go to www.emdgroup.com/subscribe to register for your online subscription of this service as our geo-targeting requires new links in the email. You may later change your selection or discontinue this service.
About Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany, a vibrant science and technology company, operates across healthcare, life science and performance materials. Around 51,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2017, Merck KGaA, Darmstadt, Germany, generated sales of € 15.3 billion in 66 countries.
The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials. Since its founding 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company. For more information about Merck, KGaA, Darmstadt, Germany, visit www.emdgroup.com.
Merck KGaA today shared updates on the company’s healthcare research and development strategy, aimed at doubling R&D productivity.